Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon B Wigal

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Psychology|September 10, 2019
Laboratory School Protocol Mini-Review: Use of Direct Observational and Objective Measures to Assess ADHD Treatment Response Across the LifespanSharon B Wigal
CNS Drugs|July 23, 2009
Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adultsSharon B Wigal
Expert Opinion on Drug Metabolism & Toxicology|May 10, 2011
Pharmacokinetic evaluation of eltoprazineSharon B Wigal, Sophie Duong
Journal of Attention Disorders|July 15, 2006
The laboratory school protocol: its origin, use, and new applicationsSharon B Wigal, Timothy L Wigal
CNS Spectrums|December 6, 2007
Special considerations in diagnosing and treating attention-deficit/hyperactivity disorderSharon B Wigal, Timothy L Wigal
Expert Opinion on Pharmacotherapy|December 18, 2012
An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorderSharon B Wigal, Pooja Raja, Ankita Shukla
Expert Opinion on Drug Metabolism & Toxicology|March 15, 2012
Metabolic, toxicological, and safety considerations for drugs used to treat ADHDSophie Duong, Kara Chung, Sharon B Wigal
Postgraduate Medicine|October 26, 2012
The novel use of objective laboratory school tasks to measure stress responses in children with ADHDSharon B Wigal, Carmen Truong, Annamarie Stehli
Journal of Attention Disorders|July 4, 2007
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHDStephen V Faraone, Sharon B Wigal, Paul Hodgkins
Advances in Pediatrics|July 9, 2011
Controversies surrounding pediatric psychopharmacologyRobin Steinberg-Epstein, Teri Book, Sharon B Wigal
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Psychology|September 10, 2019
Laboratory School Protocol Mini-Review: Use of Direct Observational and Objective Measures to Assess ADHD Treatment Response Across the LifespanSharon B Wigal
CNS Drugs|July 23, 2009
Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adultsSharon B Wigal
Expert Opinion on Drug Metabolism & Toxicology|May 10, 2011
Pharmacokinetic evaluation of eltoprazineSharon B Wigal, Sophie Duong
Journal of Attention Disorders|July 15, 2006
The laboratory school protocol: its origin, use, and new applicationsSharon B Wigal, Timothy L Wigal
CNS Spectrums|December 6, 2007
Special considerations in diagnosing and treating attention-deficit/hyperactivity disorderSharon B Wigal, Timothy L Wigal
Expert Opinion on Pharmacotherapy|December 18, 2012
An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorderSharon B Wigal, Pooja Raja, Ankita Shukla
Expert Opinion on Drug Metabolism & Toxicology|March 15, 2012
Metabolic, toxicological, and safety considerations for drugs used to treat ADHDSophie Duong, Kara Chung, Sharon B Wigal
Postgraduate Medicine|October 26, 2012
The novel use of objective laboratory school tasks to measure stress responses in children with ADHDSharon B Wigal, Carmen Truong, Annamarie Stehli
Journal of Attention Disorders|July 4, 2007
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHDStephen V Faraone, Sharon B Wigal, Paul Hodgkins
Advances in Pediatrics|July 9, 2011
Controversies surrounding pediatric psychopharmacologyRobin Steinberg-Epstein, Teri Book, Sharon B Wigal
Pageof 7